Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.12 USD | +4.10% | -1.03% | +7.36% |
Mar. 01 | Truist Securities Adjusts Price Target on Astrana Health to $44 From $41, Maintains Hold Rating | MT |
Feb. 27 | Transcript : Apollo Medical Holdings, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
Financials (USD)
Sales 2024 * | 1.76B | Sales 2025 * | 2.12B | Capitalization | 1.99B |
---|---|---|---|---|---|
Net income 2024 * | 74M | Net income 2025 * | 85M | EV / Sales 2024 * | 1.08 x |
Net cash position 2024 * | 77.7M | Net cash position 2025 * | 173M | EV / Sales 2025 * | 0.85 x |
P/E ratio 2024 * |
27.2
x | P/E ratio 2025 * |
23.9
x | Employees | 1,800 |
Yield 2024 * |
0.3% | Yield 2025 * |
-
| Free-Float | 61.01% |
Latest transcript on Astrana Health, Inc.
1 day | +4.10% | ||
1 week | -1.03% | ||
Current month | -8.70% | ||
1 month | -5.56% | ||
3 months | +2.36% | ||
6 months | +33.51% | ||
Current year | +7.36% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Sim
FOU | Founder | 70 | 85-10-31 |
Brandon Sim
CEO | Chief Executive Officer | 30 | 19-05-31 |
Thomas Lam
FOU | Founder | 74 | 85-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Li Dai
BRD | Director/Board Member | 62 | 21-12-30 |
Director/Board Member | 67 | 17-12-07 | |
Director/Board Member | 67 | 19-09-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 46 M€ | +4.03% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 41.12 | +4.10% | 145,125 |
24-03-26 | 39.5 | +0.53% | 92,318 |
24-03-25 | 39.29 | -0.96% | 76,903 |
24-03-22 | 39.67 | -3.05% | 106,804 |
24-03-21 | 40.92 | -1.52% | 141,283 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.36% | 1.99B | |
+0.60% | 99.96B | |
+22.54% | 87.73B | |
+10.63% | 29.33B | |
-4.72% | 18.21B | |
-4.95% | 14.51B | |
+19.29% | 12.22B | |
+30.63% | 12B | |
-1.29% | 11.94B | |
-32.11% | 11.56B |